Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, it has launched Isoproterenol Hydrochloride Injection, USP in the United States as a therapeutic generic equivalent for ISUPREL® as approved by the U.S. Food and Drug Administration. Isoproterenol Hydrochloride Injection, USP is indicated.
ChromaDex Corp. the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, launched its flagship consumer supplement, Tru Niagen®,
StatLab Medical Products (“StatLab”), a leading developer and manufacturer of medical diagnostic supplies and equipment,announced the acquisition of Scientific Device Laboratory (“SDL”), a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, unveiled Cell Q™, the first automated quality control (QC) workcell for cell therapy manufacturing. Cell Q™ addresses a critical challenge.
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, it has launched Desmopressin Acetate for Injection in the United States as a therapeutic equivalent generic for DDAVP® for Injection (Desmopressin Acetate) approved by the U.S.